The neurochemical effects on striatal dopamine turnover rate of N-stearyl dopamine, after acute administration in rats

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 20, Issue 1, 1996, Pages 111-119

  Antoniou, Katerina ^a   Vamvakides, Alexandre ^a   Papadopoulou Daifotis, Zetta ^a   Zervou, Ifigenia ^a   Varonos, Dionisios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Autoreceptor; Dopamine; N stearyl dopamine; Rat; Serotonin; Striatum

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; AUTORECEPTOR; DOPAMINE; DOPAMINE RECEPTOR; HALOPERIDOL; HOMOVANILLIC ACID; N STEARYL DOPAMINE; SEROTONIN; SULPIRIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CORPUS STRIATUM; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROCHEMISTRY; NONHUMAN; RAT;

EID: 0029870088     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/0278-5846(95)00298-7     Document Type: Article

References (28)

1. CASEY, D.E. (1993). Dopaminergic and serotonergic aspects of acute extrapyramidal syndromes. Psychopharmacol (Clinical pharmacology in Psychiatry) 10: 101-110.
2. CLEMENTS, J.D., LESTER, A.A.J., TONG, G., JAHR, G:E:, WESTBROOK, G.L. (1992). The time course of glutamate in the synaptic cleft. Science 258: 1498-1501.
3. COOPER, J.R., BLOOM, F.E. and ROTH, R.H. (1991). The biochemical basis of neuropharmacology. Sixth Edition, Oxford University Press.
4. COSTALL, B., LIM, S.K. and NAYLOR, R.J. (1981). Characterization of the mechanisms by which purported dopamine agonist reduce spontaneous locomotor activity of mice. Eur J Pharmacol 73: 175-188.
5. COSTENTIN, J. (1991). Recepteurs dopaminergiques centraux. Therapie 46: 269-282.
6. GRACE A.A. (1991). Phasic versus tonic dopamine release and the modulation of domine system responsivity. A hypothesis for the etiology of schizophrenia. Neuroscience 41: 1-24.
7. DI CHIARA, G., PORCEDDU, M.L., VARGIU, L., ARGIOLAS, A. and GESSA, G.L. (1976). Evidence for dopamine receptors mediating sedation in the mouse brain. Nature 264 : 564-566.
8. DI GIULIO, A.M., GROPPETTI A., CATTABENI, F., GALLI, C.L., MAGGI, A., ALGERI, S. and PONZIO, F. (1978). Significance of dopamine metabolites in the evaluation of drugs acting on dopaminergic neurons. Eur J Pharmacol 52: 201-207.
9. KOLOCOURIS, N., FOSCOLOS, G.B., FYTAS, G., SAKELLARIOU, A., RAFTOPOULOS, C., PAPADOPOULOU-DAIFOTI, Z. and VAMVAKIDES, A. (1991). Amides de la dopamine avec les acides gras essentiels ou fondamentaux. Synthese et etude pharmacologique. Ann. pharmaceutiques francaises 49: 99-110.
10. LYNCH, M. (1991). Dissociation of autoreceptor activation and behavioral consequences of low-dose apomorphine treatment. Prog Neuro-Psychopharmacol. & Biol Psychiat 15: 689-98.
11. MELTZER, H.Y. (1993). Serotonin receptors and antipsychotic drug action. Psychopharmacol (Clinical Pharmacology in Psychiatry) 10: 70-81.
12. MELTZER, H.Y., KOLAKOWSKA, T., ROBERTSON, A. and TRICOU, B.J. (1983). Effect of low-dose bromocriptine in treatment of psychosis: the dopamine autoreceptor-stimulation strategy. Psychopharmacology 81: 37-41.
13. MOGENSON, G.J. and WU, M. (1991). Effects of administration of dopamine D2 agonist quinpirole on exploratory locomotion. Brain Res 551: 216-220.
14. MURRAY, A.M., HYDE, T.M., KNABLE, M.B., HERMAN, M.M., BIGELOW L.B., CARTER, J.M., WEINBERGER D.R. and KLEINMAN, J.E. (1995). Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia. J Neurosci 15: 2186-2191.
15. PAPADOPOULOU-DAIFOTIS, Z., SAKELLARIOU, A., RAFTOPOULOS, C. et VAMVAKIDES, A. (1992). Etude de la vitesse de renouvellement ou de libération de la dopamine célébrale chez le rat après administration de N-linonéyl dopamine. Ann pharmaceutiques framcaises No 50: 229-36.
16. ROTH, R. (1984). CNS dopamine autoreceptors: distribution, pharmacology and function. Ann N Y Academy of Science 430: 27-53.
17. SERRA, G., ARGIOLAS, A., KLIMEK, V., FADDA, F. and GESSA, G.L. (1979). Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine synthesis and motor activity. Life Sci 41: 415-24.
18. SHARP, T., ZETTERSTROM, T., SERIES, H.G., CARLSSON, A., GRAHAME-SMITH, D.G. and UNGERSTEDT, U. (1978). HPLC-EC analysis of catechols and indoles in rat brain dialysates Life Sci 41: 869-872.
19. SKIRBOLL, L.R., GRACE, A:A. and BUNNEY, B.S. (1976).Dopamine auto-and postsynaptic receptors: Electrophysiological evidence for differential sensitivity to dopamine agonists. Science 206: 80-82.
20. STAHLE, L. (1992), Do autoreceptors mediate dopamine agonist - induced yawning and suppression of exploration? A critical review. Psychopharmacol 106: 1-13.
21. STAHLE, L. and UNGERSTEDT, U. (1986). Effects of Neuroleptic Drugs on the Inhibition of Explorary Behaviour Induced by a Low Dose od Apomorphine: Implications for the Identity of Dopamine Receptors. Pharmacol Biochem & Behavior 25: 473-480.
22. STRANGE, P.G. (1994). Dopamine D4 receptors: curiouser and curiouser. TIPS 15: 317-319.
23. 3 ligand R-(+)-7-OH-DPAT is independent of changes in dopamine release. J Neural Transm 95: 71-74.
24. TAMMINGA, C.A., GOTTS, M.D., THAKER, G.K., ALPHS, L.D. and FOSTER, N.L. (1988). Dopamine agonist treatment of schizophrenia with n-propyl-norapomorphine. Arch Gen Psychiatry 43: 398-402.
25. 2 agonists on the release of dopamine: localization of the mechanism of action. Naunyn-Schmied Arch Pharmacol 342: 650-654.
26. VAMVAKIDES, A. (1993). Mecanisme d'action de la L-DOPA: activation dopaminergique ou inhibition glutamatergique? Ann Pharm Fr 51: 8-15.
27. 3H-dopamine by slices of rat striatum. Naunyn-Schmiedeberg's Arch Pharmacol 292: 279-287.
28. WETZEL, H. and BENKERT, O. (1993). Dopamine autoreceptor agonists in the treatment of schizophrenic disorders. Prog. Neuro-Psychopharmacol & Biol Psychiat 17: 525-540.